{"disease":{"id":"ocular-inflammatory-disease","name":"ocular inflammatory disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00331331","title":"The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease","phase":"","overall_status":"COMPLETED","enrollment_count":147,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT00357266","title":"Differences in Genes and Proteins in Active and Controlled Uveitis","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}